Editors' ChoiceCancer

Keeping it simple: A higher-yielding process for manufacturing dendritic cells

See allHide authors and affiliations

Science Translational Medicine  06 Nov 2019:
Vol. 11, Issue 517, eaaz9749
DOI: 10.1126/scitranslmed.aaz9749


An optimized protocol using a hollow-fiber bioreactor produces a complete dose of dendritic cell–based immunotherapies in a single batch.

View Full Text

Stay Connected to Science Translational Medicine